The Quantellect read.As of Nov 19, 2026, 9 active firms cover Qiagen NV: 5 rate it Buy or better, 4 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $36.00 to $55.00, a moderate spread. The average target of $46.33 sits 7% below the current $49.55. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.56 next quarter toward $2.67 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 active firms
Buy
Strong Buy00%
Buy556%
Neutral444%
Sell00%
Strong Sell00%
Based on 9 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$46.33
-6.5% downside
Average target across 9 active firms as of Nov 19, 2026 vs $49.56 current
Highest Target$55.00
Average Target$46.33
Lowest Target$36.00
Detailed analyst forecasts for QGEN
Showing 1–10 of 10 named analysts shown · 9 active firms in the rating projection
As of Nov 19, 2026, 5 of 9 active firms rate QGEN a Buy (4 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
QGEN EPS & revenue forecast
EPS · NEXT QUARTER
$0.56
Range $0.54 – $0.58 · 6 analysts · +3% YoY
Next period, 6 analysts expect Qiagen NV to earn $0.56 a share (range $0.54 – $0.58), versus $0.54 a year earlier. Full-year consensus is $2.49, growing to $2.67 the year after.
REVENUE · NEXT QUARTER
$511.6M
Range $505.3M – $520.0M · 6 analysts · +4% YoY
Revenue is expected to reach $511.6M (range $505.3M – $520.0M), +3.9% year-over-year. Full-year consensus is $2.1B, rising to $2.2B next year.
Top analysts covering Qiagen NV
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on QGEN.
#1
Luke Sergott
Barclays · Rank #267
Buy
$55.00+11.0% to target
Overall win rate
43%
+ Follow
#2
Patrick Donnelly
Citigroup · Rank #448
Neutral
$38.00-23.3% to target
Overall win rate
29%
+ Follow
#3
CW
Casey Woodring
JP Morgan
Neutral
$52.00+4.9% to target
Coverage
—
+ Follow
#4
JK
Jan Koch
Deutsche Bank
Buy
No targeton QGEN
Coverage
—
+ Follow
#5
Daniel Arias
Stifel
Neutral
$40.00-19.3% to target
Coverage
—
+ Follow
QGEN stock forecast FAQ
What is QGEN's average 12-month price target?+
The 9 active firms with a live target average $46.33 for Qiagen NV over the next 12 months, ranging from a $55.00 high to a $36.00 low, as of Nov 19, 2026.
Is QGEN stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 9 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 4 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for QGEN?+
The Street-high target is $55.00 (JP Morgan), and the Street-low is $36.00 (Stifel). The average of all 9 active-firm targets is $46.33.
How many active Wall Street firms cover QGEN?+
9 active firms have a recognized rating on Qiagen NV as of Nov 19, 2026, and 9 active firms carry a live 12-month price target.
Who is the most accurate analyst covering QGEN?+
Among analysts who currently cover QGEN, Luke Sergott of Barclays has the strongest overall Quantellect track record (Rank #267). Their current call is Buy with a $55.00 target.
What is Qiagen NV's projected EPS for next quarter?+
The consensus estimate is $0.56 per share (range $0.54 – $0.58) across 6 analysts. Full-year EPS is projected at $2.49, rising to $2.67 the following year.
How much revenue is Qiagen NV expected to report next quarter?+
Consensus revenue is $511.6M (range $505.3M – $520.0M). Full-year revenue is projected at $2.1B, growing to $2.2B next year.
Have analysts been upgrading or downgrading QGEN lately?+
As of Nov 19, 2026, 5 of 9 active firms rate QGEN a Buy (4 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their QGEN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.